🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Enimmune Corporation (TPEX:6564)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.60
-1.10 (-7.48%)
Nov 20, 2026, 1:50 PM CST

Enimmune Revenue

Enimmune had revenue of 27.90M TWD in the half year ending June 30, 2026, with 37.26% growth. This brings the company's total for the last twelve months to 53.45M, up 26.56% year-over-year. In the year 2025, Enimmune had annual revenue of 48.19M with 20.74% growth. That makes Enimmune the 42,804th largest company in the world by revenue and 2,138th in Taiwan.

Revenue (ttm)
53.45M
Revenue Growth
+26.56%
P/S Ratio
18.35
Revenue / Employee
n/a
Employees
38
Market Cap
981.02M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202548.19M8.28M20.74%
Dec 31, 202439.92M-3.58M-8.23%
Dec 31, 202343.49M-144.92M-76.92%
Dec 31, 2022188.42M78.59M71.56%
Dec 31, 2021109.82M86.95M380.08%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.